Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.724 $1.29 Friday, 10th May 2024 DRRX stock ended at $1.06. This is 6.19% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 16.83% from a day low at $1.01 to a day high of $1.18.
90 days $0.724 $1.44
52 weeks $0.470 $7.46

Historical Durect Corporation prices

Date Open High Low Close Volume
Oct 20, 2016 $1.19 $1.24 $1.17 $1.23 401 700
Oct 19, 2016 $1.28 $1.28 $1.17 $1.21 512 700
Oct 18, 2016 $1.29 $1.30 $1.25 $1.28 227 600
Oct 17, 2016 $1.21 $1.36 $1.18 $1.28 772 100
Oct 14, 2016 $1.22 $1.25 $1.20 $1.21 352 000
Oct 13, 2016 $1.20 $1.26 $1.20 $1.23 473 400
Oct 12, 2016 $1.25 $1.26 $1.18 $1.23 470 600
Oct 11, 2016 $1.32 $1.35 $1.22 $1.25 564 100
Oct 10, 2016 $1.30 $1.37 $1.29 $1.33 462 200
Oct 07, 2016 $1.31 $1.35 $1.30 $1.30 370 600
Oct 06, 2016 $1.35 $1.39 $1.28 $1.30 365 800
Oct 05, 2016 $1.35 $1.39 $1.30 $1.36 277 800
Oct 04, 2016 $1.36 $1.40 $1.32 $1.35 354 000
Oct 03, 2016 $1.40 $1.45 $1.33 $1.36 670 000
Sep 30, 2016 $1.34 $1.41 $1.30 $1.39 1 088 300
Sep 29, 2016 $1.40 $1.42 $1.31 $1.34 723 700
Sep 28, 2016 $1.38 $1.42 $1.25 $1.40 3 789 400
Sep 27, 2016 $1.22 $1.41 $1.22 $1.39 5 881 500
Sep 26, 2016 $1.20 $1.22 $1.08 $1.16 11 338 600
Sep 23, 2016 $1.76 $1.76 $1.56 $1.70 1 406 900
Sep 22, 2016 $1.75 $1.76 $1.68 $1.74 890 700
Sep 21, 2016 $1.78 $1.79 $1.70 $1.73 908 200
Sep 20, 2016 $1.74 $1.76 $1.68 $1.75 1 162 600
Sep 19, 2016 $1.66 $1.69 $1.65 $1.68 593 100
Sep 16, 2016 $1.62 $1.68 $1.58 $1.64 1 282 400
Click to get the best stock tips daily for free!

About Durect Corporation

Durect DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in... DRRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT